Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1993-11-17
|
pubmed:abstractText |
The prolactin secretory response to beta-endorphin and the involvement of opiate receptor subtypes in this response was determined in both diestrous and postpartum, lactating female rats. The involvement of the mu-, delta- and/or kappa-site was determined by administering specific antagonists for each of these sites prior to beta-endorphin. beta-Funaltrexamine (beta-FNA, 1 or 5 micrograms) was administered to block mu-sites, ICI 154,129 (5, 10 or 25 micrograms) blocked delta-sites and nor-binaltorphimine (norBNI, 8 micrograms) blocked kappa-sites. The ability of beta-FNA and ICI 154,129 to block prolactin secretion following morphine administration was also determined. A dose response study for beta-endorphin indicated that beta-endorphin, at doses as low as 25 ng, was a potent stimulus for prolactin release producing an increase in prolactin that mimicked the suckling-induced prolactin increase. In addition, all three antagonists were capable of antagonizing the stimulatory effect of beta-endorphin in both diestrous and postpartum female rats. These results indicate that beta-endorphin is a potent stimulus for prolactin secretion and that these three opiate receptor subtypes interact to produce its stimulatory effect on prolactin release.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Enkephalin, Leucine,
http://linkedlifedata.com/resource/pubmed/chemical/ICI 154129,
http://linkedlifedata.com/resource/pubmed/chemical/Naltrexone,
http://linkedlifedata.com/resource/pubmed/chemical/Prolactin,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Opioid,
http://linkedlifedata.com/resource/pubmed/chemical/beta-Endorphin,
http://linkedlifedata.com/resource/pubmed/chemical/beta-funaltrexamine,
http://linkedlifedata.com/resource/pubmed/chemical/norbinaltorphimine
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0028-3835
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
57
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
875-83
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8413824-Animals,
pubmed-meshheading:8413824-Diestrus,
pubmed-meshheading:8413824-Dose-Response Relationship, Drug,
pubmed-meshheading:8413824-Enkephalin, Leucine,
pubmed-meshheading:8413824-Female,
pubmed-meshheading:8413824-Lactation,
pubmed-meshheading:8413824-Male,
pubmed-meshheading:8413824-Naltrexone,
pubmed-meshheading:8413824-Prolactin,
pubmed-meshheading:8413824-Rats,
pubmed-meshheading:8413824-Rats, Sprague-Dawley,
pubmed-meshheading:8413824-Receptors, Opioid,
pubmed-meshheading:8413824-beta-Endorphin
|
pubmed:year |
1993
|
pubmed:articleTitle |
Opiate receptor subtype involvement in the stimulation of prolactin release by beta-endorphin in female rats.
|
pubmed:affiliation |
Zoology Department, Miami University, Oxford, Ohio 45056.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|